Pantoprazole Sodium Delayed-Release is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Pantoprazole Sodium.
| Product ID | 43353-338_d210a49a-4415-4bb1-b333-8027e459711b |
| NDC | 43353-338 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pantoprazole Sodium Delayed-Release |
| Generic Name | Pantoprazole Sodium |
| Dosage Form | Tablet, Delayed Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2008-01-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020987 |
| Labeler Name | Aphena Pharma Solutions - Tennessee, LLC |
| Substance Name | PANTOPRAZOLE SODIUM |
| Active Ingredient Strength | 40 mg/1 |
| Pharm Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2008-01-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020987 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-01-31 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA020987 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-07-19 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA020987 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-01-31 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA020987 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2008-01-31 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA020987 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-07-19 |
| Inactivation Date | 2020-01-31 |
| Marketing Category | NDA |
| Application Number | NDA020987 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-07-19 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| PANTOPRAZOLE SODIUM | 40 mg/1 |
| SPL SET ID: | 03974abc-ad03-44da-b7b6-d8e6c4a06105 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 43353-338 | Pantoprazole Sodium Delayed-Release | Pantoprazole Sodium Delayed-Release |
| 63187-005 | Pantoprazole Sodium Delayed-Release | Pantoprazole Sodium Delayed-Release |
| 67046-535 | Pantoprazole Sodium Delayed-Release | Pantoprazole Sodium Delayed-Release |
| 0093-0011 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0093-0012 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0143-9284 | Pantoprazole Sodium | Pantoprazole Sodium |
| 0008-0841 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0843 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0844 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0923 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-0941 | Protonix | pantoprazole sodium |
| 0008-2001 | Protonix | PANTOPRAZOLE SODIUM |
| 0008-4001 | Protonix | PANTOPRAZOLE SODIUM |